Ardiyon Bio
PrivateLast Round
Accelerator
Jan 1, 2025
Total Funding Raised
$40,000
Company Overview
Ardiyon Bio is a biotechnology company developing a targeted enzyme replacement therapy for systemic lupus erythematosus and related autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ardiyon Bio Comparables
Compare Ardiyon Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neutrolis Inc | 86% | |
| Resolve Therapeutics | 76% | |
| AstraZeneca | 66% | |
Ardiyon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 1, 2025 |
Ardiyon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Texas Tech Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
$40K round from Texas Tech Accelerator
Ardiyon Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ardiyon Bio's valuation, stock price, and market status.